Japan is the world’s 3rd largest economy and 3rd largest healthcare market with its own business traditions and healthcare system.
Since 2019 we have been working very closely together with KOBE Biomedical Innovation Cluster (KBIC) to support European companies in accessing the Japanese market and vice versa. Most of KBIC’s 370+ members are from the industry including companies from medical devices, pharmaceutical and regenerative medicine sectors. In cooperation with KBIC’s main subsidiary, the Foundation for Biomedical Research and Innovation at Kobe (FBRI), we are offering support on the following topics:
Acquisition of funds